Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Anti-EGFR and radiotherapy].

G Milano1, N Magné

  • 1Laboratoire d'oncopharmacologie, centre Antoine-Lacassagne, 33, avenue de Valombrose, 06189 Nice 2, France. gerard.milano@nice.fnclcc.fr

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|December 28, 2004
PubMed
Summary

Epidermal Growth Factor Receptor (EGFR) targeted therapies enhance radiation's antitumor effects by blocking cancer cell growth pathways. Clinical trials are exploring combinations of EGFR inhibitors and radiotherapy for improved cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Italian version of the Majeed pelvic score: translation, cross-cultural adaptation and validation.

Musculoskeletal surgery·2024
Same author

The Musculoskeletal Tumor Society Scoring system is a valid subjective and objective tool to evaluate outcomes of surgical treatment of patients affected by upper and lower extremity tumors.

Musculoskeletal surgery·2024
Same author

Cross-cultural adaptation and validation of the Italian version of the Western Ontario Rotator Cuff (WORC) index.

Musculoskeletal surgery·2024
Same author

The systemic deletion of interleukin-1α reduces myocardial inflammation and attenuates ventricular remodeling in murine myocardial infarction.

Scientific reports·2023
Same author

Impact of EGFR<sup>A289T/V</sup> mutation on relapse pattern in glioblastoma.

ESMO open·2022
Same author

Recommendations for stereotactic body radiation therapy for spine and non-spine bone metastases. A GETUG (French society of urological radiation oncolgists) consensus using a national two-round modified Delphi survey.

Clinical and translational radiation oncology·2022

Area of Science:

  • Oncology
  • Molecular Biology
  • Radiotherapy

Background:

  • Epidermal Growth Factor Receptor (EGFR) is a transmembrane protein frequently implicated in epithelial cancer progression.
  • EGFR activation triggers intracellular signaling pathways crucial for cell proliferation, apoptosis inhibition, and angiogenesis.

Purpose of the Study:

  • To review the mechanisms by which EGFR-targeted therapies enhance the antitumor activity of ionizing radiation.
  • To discuss the rationale for combining EGFR inhibitors with radiotherapy in clinical settings.

Main Methods:

  • Review of scientific literature discussing EGFR signaling pathways and targeted therapies (monoclonal antibodies, tyrosine-kinase inhibitors).
  • Analysis of proposed mechanisms for radiosensitization by EGFR modulation.

Related Experiment Videos

  • Examination of ongoing clinical trials investigating combined EGFR inhibition and radiotherapy.

    • Main Results:

    • EGFR-targeted agents can block key cancer-promoting pathways activated by EGFR.
    • These agents demonstrate potential to enhance the efficacy of ionizing radiation in preclinical and clinical settings.
    • Several mechanisms, including improved DNA damage repair, facilitated apoptosis, and inhibited tumor repopulation, are proposed.

    Conclusions:

    • Targeting EGFR offers a promising strategy to potentiate radiotherapy for epithelial cancers.
    • The combination of EGFR inhibitors and radiotherapy is supported by mechanistic data and is under active clinical investigation.
    • Further research and clinical trials are essential to optimize combined treatment protocols.